Speaking anonymously, a high-ranking source in the Health Ministry stated that talks with COVAX, a worldwide effort to promote equitable access to Coronavirus vaccinations that is lead by GAVI, are at an advanced stage.
So yet, no specific information on the quantity of doses of COVID-19, the country’s primary vaccine, and its expected arrival date in Pakistan has been made available.
Moderna’s vaccine is comprised of two doses given two weeks apart. after the initial dosage, efficacy is 50.8%; after the booster dose, efficacy is 92.1% The vaccination has been given a second time two weeks following the initial dosage, and is now 94.1% effective at preventing the Coronavirus.
However, because Moderna has not yet applied for an EUA with the Drug Regulatory Authority of Pakistan, they do not have an EUA” (DRAP).
Assuming the application for DRAP clearance is approved, this will be the 7th COVID-19 vaccination to be given in Pakistan with EUA.
For now, three Chinese vaccines produced by Sinopharm, Cansino, and Sinovac have been authorized by DRAP. The remaining three vaccines that have received approval from DRAP are Russia’s Sputnik V, AstraZeneca’s AZD1222, and Pfizer’s BNT162b2.